Movement context modulates neuronal activity in motor and limbic-associative domains of the human parkinsonian subthalamic nucleus.


Journal

Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169

Informations de publication

Date de publication:
03 2020
Historique:
received: 15 09 2019
revised: 08 12 2019
accepted: 13 12 2019
pubmed: 18 12 2019
medline: 5 1 2021
entrez: 18 12 2019
Statut: ppublish

Résumé

The subthalamic nucleus (STN), a preferred target for treating movement disorders, has a crucial role in inhibition and execution of movement. To better understand the mechanism of movement regulation in the STN of Parkinson's disease patients, we compared the same movement with different context, facilitation vs. inhibition context. We recorded subthalamic multiunit activity intra-operatively while parkinsonian patients (off medications, n = 43 patients, 173 recording sites) performed increasingly complex oddball paradigms with frequent and deviant tones: first, passive listening to tone series with no movement ('None-Go' task, n = 7, 28 recording sites); second, pressing a button after every tone ('All-Go' task, n = 7, 26 recording sites); and third, pressing a button only for frequent tones, thus adding inhibition of movement following deviant tones ('Go-NoGo' task, n = 29, 119 recording sites). The STN responded mainly to movement-involving tasks. In the limbic-associative STN, evoked response to the deviant tone (inhibitory cue) was not significantly different between the Go-NoGo and the All-Go task. However, the evoked response to the frequent tone (go cue) in the Go-NoGo task was significantly reduced. The reduction was mainly prominent in the negative component of the evoked response amplitude aligned to the press. Successful movement inhibition was correlated with higher baseline activity. We suggest that the STN in Parkinson's disease patients adapts to movement inhibition context by selectively decreasing the amplitude of neuronal activity. Thus, the STN enables movement inhibition not by increasing responses to the inhibitory cue but by reducing responses to the release cue. The negative component of the evoked response probably facilitates movement and a higher baseline activity enables successful inhibition of movement. These discharge modulations were found in the ventromedial, non-motor domain of the STN and therefore suggest a significant role of the limbic- associative STN domains in movement planning and in global movement regulation.

Identifiants

pubmed: 31846735
pii: S0969-9961(19)30391-2
doi: 10.1016/j.nbd.2019.104716
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104716

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Odeya Marmor (O)

Department of Medical Neurobiology (Physiology), Institute of Medical Research - Israel- Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel. Electronic address: odaya.marmor-levine@mail.huji.ac.il.

Pnina Rappel (P)

Department of Medical Neurobiology (Physiology), Institute of Medical Research - Israel- Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel; The Edmond and Lily Safra Center for Brain Research, The Hebrew University, Jerusalem, Israel.

Dan Valsky (D)

Department of Medical Neurobiology (Physiology), Institute of Medical Research - Israel- Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel; The Edmond and Lily Safra Center for Brain Research, The Hebrew University, Jerusalem, Israel.

Atira S Bick (AS)

Department of Medical Neurobiology (Physiology), Institute of Medical Research - Israel- Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel; The Brain Division, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

David Arkadir (D)

The Brain Division, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Eduard Linetsky (E)

The Brain Division, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Or Peled (O)

The Brain Division, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Idit Tamir (I)

The Brain Division, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; The Center for Functional and Restorative Neurosurgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Hagai Bergman (H)

Department of Medical Neurobiology (Physiology), Institute of Medical Research - Israel- Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel; The Edmond and Lily Safra Center for Brain Research, The Hebrew University, Jerusalem, Israel; The Brain Division, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Zvi Israel (Z)

The Brain Division, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; The Center for Functional and Restorative Neurosurgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Renana Eitan (R)

Department of Medical Neurobiology (Physiology), Institute of Medical Research - Israel- Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel; The Brain Division, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Neuropsychiatry Unit, The Jerusalem Mental Health Center, Jerusalem, Israel; Functional Neuroimaging Laboratory, Brigham and Women's Hospital, Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH